Managing antibody stability: Effects of stressors on Ipilimumab from the commercial formulation to diluted solutions.
Eur J Pharm Biopharm
; 176: 54-74, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35595030
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Stability
/
Ipilimumab
/
Antineoplastic Agents, Immunological
Limits:
Humans
Language:
En
Journal:
Eur J Pharm Biopharm
Journal subject:
FARMACIA
/
FARMACOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Italy